Neurology Central

Novel enzyme pathway implicated in ALS

Researchers from the University of Missouri (MO, USA) have recently identified a potential therapeutic target for amyotrophic lateral sclerosis (ALS) that has the potential to lessen the severity and progression of the disease. Recently published in Cell Reports, the research reports this same enzyme pathway could also be target for recovery of patients who have suffered stroke and other neurological diseases.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.